As of April 29, 2025, Cingulate (CING) has a market cap of $15.752 million USD. According to our data, Cingulate is ranked No.8656 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 29, 2025 | $15.75 M |
-0.53%
|
Dec 31, 2024 | $15.84 M |
-94.63%
|
Dec 29, 2023 | $0.29 B |
-61.75%
|
Dec 30, 2022 | $0.77 B |
-63.77%
|
Dec 31, 2021 | $2.13 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() ACADIA Pharmaceuticals
ACAD
|
$2.41 B |
0.000 M
|
![]() USA
|
![]() Axsome Therapeutics
AXSM
|
$5.36 B |
0.000 M
|
![]() USA
|
![]() Intra-Cellular Therapies
ITCI
|
$14.05 B |
0.000 M
|
![]() USA
|
![]() Sage Therapeutics
SAGE
|
$0.48 B |
-0.000 M
|
![]() USA
|
![]() BioXcel Therapeutics
BTAI
|
$10.88 M |
0.000 M
|
![]() USA
|
![]() Alkermes
ALKS
|
$4.74 B |
0.000 M
|
![]() Ireland
|
![]() Neurocrine Biosciences
NBIX
|
$10.61 B |
-0.000 M
|
![]() USA
|
![]() Vanda Pharmaceuticals
VNDA
|
$0.26 B |
0.000 M
|
![]() USA
|
![]() Jazz Pharmaceuticals
JAZZ
|
$7.17 B |
-0.000 M
|
![]() Ireland
|
![]() Teva Pharmaceutical Industries
TEVA
|
$18.23 B |
0.362 B
|
![]() Israel
|
![]() Eli Lilly
LLY
|
$794.90 B |
-0.026 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$375.13 B |
0.006 M
|
![]() USA
|
Market Cap | = | CING Stock Price | * | CING Shares Outstanding |
= | $4.18 | * | 3.77 M | |
= | $15.75 M |